Bruker Posts 33 Percent Rise in Q2 Revenues, Notes Strong Interest in New Mass Spec Systems
August 05, 2011
Bruker Posts 33 Percent Rise in Q2 Revenues, Notes Strong Interest in New Mass Spec Systems
While CEO Frank Laukien noted that recent mass spec releases like the maXis 4G UHR-QTOF and the maXis Impact likely hadn't contributed to the rising Q2 revenues, "order uptake is strong" for the new instruments, he said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- ASMS 2011 Highlights TOF Technology, Continued Emphasis on Qual-Quant Workflows
June 10, 2011 / ProteoMonitor - New Bruker Mass Spec Machine Leads Product Releases at Quiet Pittcon 2011
March 18, 2011 / ProteoMonitor - Bruker's Q1 Revenues Up 29 Percent
April 29, 2011 / ProteoMonitor - Bruker Gets Health Canada Approval for IVD MALDI Biotyper, Closes Michrom Acquisition
April 8, 2011 / ProteoMonitor - New Products
March 18, 2011 / ProteoMonitor